JP2012507308A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012507308A5 JP2012507308A5 JP2011535539A JP2011535539A JP2012507308A5 JP 2012507308 A5 JP2012507308 A5 JP 2012507308A5 JP 2011535539 A JP2011535539 A JP 2011535539A JP 2011535539 A JP2011535539 A JP 2011535539A JP 2012507308 A5 JP2012507308 A5 JP 2012507308A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- oligonucleotide
- oligonucleotide according
- isolated
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11128708P | 2008-11-04 | 2008-11-04 | |
| US61/111,287 | 2008-11-04 | ||
| SE0802339 | 2008-11-04 | ||
| SE0802339-2 | 2008-11-04 | ||
| PCT/SE2009/051247 WO2010053435A2 (en) | 2008-11-04 | 2009-11-04 | Compounds and methods for the treatment of inflammatory diseases of the cns |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012507308A JP2012507308A (ja) | 2012-03-29 |
| JP2012507308A5 true JP2012507308A5 (enExample) | 2012-12-06 |
| JP5746038B2 JP5746038B2 (ja) | 2015-07-08 |
Family
ID=42153438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011535539A Expired - Fee Related JP5746038B2 (ja) | 2008-11-04 | 2009-11-04 | Ｃｎｓの炎症性疾患の治療のための化合物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8637479B2 (enExample) |
| EP (1) | EP2350283B1 (enExample) |
| JP (1) | JP5746038B2 (enExample) |
| AU (1) | AU2009311753B2 (enExample) |
| CA (1) | CA2778961C (enExample) |
| DK (1) | DK2350283T3 (enExample) |
| ES (1) | ES2560782T3 (enExample) |
| WO (1) | WO2010053435A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010053430A1 (en) | 2008-11-04 | 2010-05-14 | Index Pharmaceuticals Ab | Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
| EP2468866A1 (en) * | 2010-12-21 | 2012-06-27 | Index Pharmaceuticals AB | Biologically active oligonucleotides capable of modulating the immune system |
| WO2012084991A1 (en) * | 2010-12-21 | 2012-06-28 | Index Pharmaceuticals Ab | Biologically active oligonucleotides capable of modulating the immune system ii |
| EP2596806A1 (en) | 2011-11-25 | 2013-05-29 | Index Pharmaceuticals AB | Method for prevention of colectomy |
| WO2019006122A1 (en) * | 2017-06-28 | 2019-01-03 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | HOT EXTRUSION FOR VAGINAL FILM PHARMACEUTICAL PRODUCTS |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR040996A1 (es) * | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
| AU2004255470B2 (en) * | 2003-07-10 | 2010-08-19 | Cytos Biotechnology Ag | Packaged virus-like particles |
| US20110070575A1 (en) * | 2004-12-08 | 2011-03-24 | Coley Pharmaceutical Group, Inc. | Immunomodulatory Compositions, Combinations and Methods |
| WO2006065751A2 (en) * | 2004-12-13 | 2006-06-22 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods |
| SI2179737T1 (sl) * | 2005-07-01 | 2014-02-28 | Index Pharmaceuticals Ab | Modulacija reakcije na stereoide |
| ATE476193T1 (de) * | 2005-07-01 | 2010-08-15 | Index Pharmaceuticals Ab | Immunstimulatorisches verfahren |
| EP1940419A2 (en) * | 2005-09-09 | 2008-07-09 | Oregon Health and Science University | Neuroprotectants |
| EP1940472A1 (en) * | 2005-10-28 | 2008-07-09 | Index Pharmaceuticals AB | Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
| WO2007095316A2 (en) | 2006-02-15 | 2007-08-23 | Coley Pharmaceutical Gmbh | Compositions and methods for oligonucleotide formulations |
| EP1894941A1 (en) * | 2006-09-01 | 2008-03-05 | Institut Pasteur | Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens |
| EP2573176B1 (en) * | 2007-05-04 | 2016-04-06 | InDex Pharmaceuticals AB | Tumour growth inhibitory compounds and methods of their use |
| EP2155889A4 (en) * | 2007-05-25 | 2010-06-16 | Centocor Ortho Biotech Inc | TOLL RECEPTOR 3 MODULATORS AND USES THEREOF |
| WO2009045145A1 (en) * | 2007-10-05 | 2009-04-09 | Index Pharmaceuticals Ab | Novel compounds for the treatment or alleviation of edema, and methods for their use |
| AU2009260907A1 (en) * | 2008-06-18 | 2009-12-23 | Index Pharmaceuticals Ab | Combination therapies against cancer |
| WO2010053430A1 (en) * | 2008-11-04 | 2010-05-14 | Index Pharmaceuticals Ab | Compounds and methods for reducing the recruitment and/or migration of polymorphonuclear cells |
-
2009
- 2009-11-04 CA CA2778961A patent/CA2778961C/en active Active
- 2009-11-04 ES ES09825063.2T patent/ES2560782T3/es active Active
- 2009-11-04 AU AU2009311753A patent/AU2009311753B2/en not_active Ceased
- 2009-11-04 JP JP2011535539A patent/JP5746038B2/ja not_active Expired - Fee Related
- 2009-11-04 US US13/127,190 patent/US8637479B2/en active Active
- 2009-11-04 EP EP09825063.2A patent/EP2350283B1/en active Active
- 2009-11-04 WO PCT/SE2009/051247 patent/WO2010053435A2/en not_active Ceased
- 2009-11-04 DK DK09825063.2T patent/DK2350283T3/en active
-
2014
- 2014-01-06 US US14/148,483 patent/US20140128456A1/en not_active Abandoned
-
2018
- 2018-01-08 US US15/864,396 patent/US20180230463A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012507308A5 (enExample) | ||
| AU2020260479B2 (en) | Methods and Compositions for the Specific Inhibition of Alpha-1 Antitrypsin by Double-Stranded RNA | |
| JP2013504542A5 (enExample) | ||
| Zhang et al. | LncRNA MEG8 regulates vascular smooth muscle cell proliferation, migration and apoptosis by targeting PPARα | |
| KR101589442B1 (ko) | 에스디에프-1 결합형 핵산 및 이의 용도 | |
| ES2749855T3 (es) | Procedimientos y composiciones para la inhibición específica de glicolato oxidasa (hao1) por ARN bicatenario | |
| WO2009044392A3 (en) | Novel sirna structures | |
| CN102099474B (zh) | 用于治疗炎症和赘生性细胞增殖的寡核苷酸 | |
| ES2873893T3 (es) | Métodos y composiciones para la inhibición específica de beta-catenina por RNA bicatenario | |
| JP2011500858A5 (enExample) | ||
| IL303077A (en) | Oligonucleotides to reduce expression of PD–L1 | |
| JP2009529916A5 (enExample) | ||
| WO2010151755A2 (en) | TREATMENT OF INFLAMMATORY DISEASES USING miR-124 | |
| CN103298475A (zh) | 作为治疗剂的寡核苷酸类似物的设计 | |
| KR20150119924A (ko) | 백신 애쥬번트 및 치료제로서의 짧은 올리고뉴클레오티드의 설계 | |
| Shan et al. | Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke | |
| JP2009506122A5 (enExample) | ||
| JP2013530965A5 (enExample) | ||
| KR20180089531A (ko) | Tlr 저해성 올리고뉴클레오티드 및 그의 용도 | |
| CN104004762B (zh) | Tgf-r反义序列及其在制备抗气道炎症反应药物中的应用 | |
| Roh et al. | Fumaric acid attenuates the eotaxin-1 expression in TNF-α-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling | |
| AU2023254203A1 (en) | Lipid nanoparticles for gene editing systems | |
| CN104278030A (zh) | 小分子化合物Antagomir-31制备方法及应用 | |
| US9387221B2 (en) | SDF-1 binding nucleic acids and the use thereof in cancer treatment | |
| CA2864766C (en) | Guanosine-rich oligonucleotide (gro) compositions, methods and uses for treating respiratory syncytial virus infection |